Table 3 Facilitators and barriers to recruitment in order of frequency of responses
From: A survey of facilitators and barriers to recruitment to the MAGNETIC trial
Facilitators | n (%) | Barriers | n (%) |
|---|---|---|---|
Motivation of MAGNETIC study team at site | 131 (78.9) | Clinical workload | 146 (87.3) |
Communication and coordination between study team members at site | 123 (74.5) | Shift patterns of work | 129 (77.7) |
Communication skills of clinical team | 116 (70.3) | Number of trained staff | 130 (77.3) |
Presence of designated research nurse/practitioner | 113 (68.1) | Time and setting of consent seeking | 127 (76) |
Research experience of PI and study team members at site | 105 (63.3) | GCP training | 116 (69.6) |
Publicity by the trial team | 103 (62.9) | Time to complete administrative work related to the trial | 112 (66.6) |
Communication and coordination between study team at site and Clinical Trials Unit (CTU) | 103 (62.1) | Parents’ concerns about side effects of new drug | 109 (65.3) |
Trial management | 101 (62) | Parents’ attitude towards their child taking experimental medicine or placebo | 95 (57.2) |
Clinician attitude to involving patients in research | 101 (60.9) | Availability of research staff out of hours | 95 (57) |
Perceived importance of the particular research question | 99 (60.1) | Difficulty in approaching patients for consent | 90 (53.9) |
Availability of designated research team | 97 (58.4) | Local clinical arrangements | 86 (52.1) |
Clarity in presentation of trial information | 97 (58.4) | Seasonal variation | 86 (51.8) |
Patient inclusion criteria | 96 (57.5) | Language or cultural barriers | 84 (50.3) |
Motivation of clinical team | 89 (53.6) | Amount and complexity of trial information provided | 83 (50) |
Experience and training of clinical team seeking consent | 84 (50.4) | ||
Communication between research team and parents | 83 (50.1) |